Edit Template

Home

Boulder Peptide Foundation

A nonprofit dedicated to advancing peptide science to create life-changing therapeutics, materials, and diagnostics for the benefit of humanity.

Sept 28 - Oct 01, 2026

Boulder Peptide Foundation

A nonprofit dedicated to advancing peptide science to create life-changing therapeutics, materials, and diagnostics for the benefit of humanity.

Sept 28 - Oct 01, 2026

Boulder Peptide Foundation

A nonprofit dedicated to advancing peptide science to create life-changing therapeutics, materials, and diagnostics for the benefit of humanity.

Sept 28 - Oct 01, 2026

Boulder Peptide Foundation

A nonprofit dedicated to advancing peptide science to create life-changing therapeutics, materials, and diagnostics for the benefit of humanity.

Boulder Peptide Foundation
A nonprofit dedicated to advancing peptide science to create life-changing therapeutics, materials, and diagnostics for the benefit of humanity.
Boulder Peptide Foundation
A nonprofit dedicated to advancing peptide science to create life-changing therapeutics, materials, and diagnostics for the benefit of humanity.
Boulder Peptide Foundation
A nonprofit dedicated to advancing peptide science to create life-changing therapeutics, materials, and diagnostics for the benefit of humanity.

2026 BPS in Napa

  • Sept 28 – Oct 1, 2026

January
Journal Club

Peptide-Drug Conjugates: Where Are We in 2025

  • Jan 06, 2026

BPS 2025 Videos

  • Sept 15-18, 2025

BPS 2025 Gallery

  • Sept 15-18, 2025

Confirmed Speakers For BPS 2025

Justin Northrup

Head of R&D
ThirdLaw Molecular

Application of a 4.5 Billion Member DNA Encoded Library of Spiroligomer[TM] Macromolecules to Discover Low Nanomolar Binders for TNF-alpha

Kaveh Matinkhoo

Associate Director Chemistry
Alpha-9 Oncology
Peptide Radiopharmaceutical Panel

Tom Tucker

Principal Scientist
Merck and Co. Inc.
Discovery of the Highly Potent and Orally Bioavailable Cyclic Peptide PCSK9 Inhibitor MK-0616

Stephanie

Chief Reproductive Unit
Mass General Brigham
A Kiss to Remember

David Waqner

Chief Scientific Officer
University of Colorado

OPT101, A Peptide Targeting CD40 – CD154 Interaction Completed Phase 1 Clinical Trial

Kathy Miller

Ballve-Lanntero Professor
Indiana University
Peptide vaccines for prevention and treatment of cancer

Aaron Enke

Sr. Director, Clinical Science
3B Pharmaceuticals GmbH
Peptide Radiopharmaceutical Panel

John Phipps

VP of Clinical Pipeline Dev
CPC Scientist
Reduction in Impurities Formed During Large-Scale Semaglutide Synthesis

Daniel Kessler

Group Leader Project Manager
Bachem
CMC development for peptide API

Dominik Sarma

Senior Market Manager
Gyros Protein Techno
Simplified catch-and-release protocol transforms difficult-to-dissolve peptides into routine purifications
View All Speakers

Explore Our Symposium

The Boulder Peptide Foundation is dedicated to advancing peptide science to support the development of novel therapeutics, biomaterials, medical diagnostics, and other innovations that benefit humanity.

Our primary vehicle this mission is the Boulder Peptide Symposium—an annual event that brings together leading minds from across the field. Attendees often describe the Symposium as something truly special: a unique blend of cutting-edge presentations, thought-provoking discussions, and opportunities for networking. 

Set in stunning locations and complemented by fun social events, the conference leaves a lasting impression on all who attend.

Attendees from Pharma, Emerging Biotech Labs, and Experienced Consultants

0 %

Attendees are Academic Researchers with cutting edge technology and tools

0 %

Sessions focusing on Clinical Development, Drug Delivery, and Complex Chemistry, along with two ‘hot topic’ panel discussions

0

Dedicated poster sessions include a poster competition with monetary awards for outstanding presentations.

0

Symposium Sponsors for BPS 2026

Bachem

Bachem

Bachem is a leading, innovation-driven company

CPC Scientific

CPC Scientific

Your Reliable CDMO Partner for GMP Peptide Manufacturing

View All Sponsors

Log in to Continue

Log In with Linkedin
or

Don’t Have an Account Sign up

Forgot Password

Confirmed Speakers For BPS 2025

Justin Northrup

Head of R&D
ThirdLaw Molecular

Application of a 4.5 Billion Member DNA Encoded Library of Spiroligomer[TM] Macromolecules to Discover Low Nanomolar Binders for TNF-alpha

Kaveh Matinkhoo

Associate Director Chemistry
Alpha-9 Oncology

Peptide Radiopharmaceutical Panel

Tom Tucker

Principal Scientist
Merck and Co. Inc.

Discovery of the Highly Potent and Orally Bioavailable Cyclic Peptide PCSK9 Inhibitor MK-0616

Stephanie

Chief Reproductive Unit
Mass General Brigham

A Kiss to Remember

Kathy Miller

Ballve-Lanntero Professor
Indiana University

Peptide vaccines for prevention and treatment of cancer

Aaron Enke

Sr. Director, Clinical Science
3B Pharmaceuticals GmbH

Peptide Radiopharmaceutical Panel

John Phipps

VP of Clinical Pipeline Dev
CPC Scientist

Reduction in Impurities Formed During Large-Scale Semaglutide Synthesis

Daniel Kessler

Group Leader Project Manager
Bachem
CMC development for peptide API

Dominik Sarma

Senior Market Manager
Gyros Protein Techno

Simplified catch-and-release protocol transforms difficult-to-dissolve peptides into routine purifications

David Waqner

Chief Scientific Officer
University of Colorado

OPT101, A Peptide Targeting CD40 – CD154 Interaction Completed Phase 1 Clinical Trial

Past Meetings

BPS 2025

Sep 15-18, 2025
(Boulder, CO)

Photos
Proceedings

Highlights:

  • YI Award: Dr. Anne Conibear
  • Spotlight on peptides in women’s health research
  • Panel: Peptides as Radiopharmaceuticals
  • Workshop - AI/Machine Learning with Peptides

BPS 2024

Photos
Proceedings

Sep 16-19, 2024
(Boulder, CO)

Highlights:

  • Meienhofer Keynote: Dr. Femando Albericio
  • Spotlight on peptides in addiction research
  • Panel: Diversity in Clinical Trials
  • Preclinical Develoment Discussion

BPS 2023

Photos
Proceedings

Sep 18-21, 2023
(Napa, CA)

Highlights:

  • Yl Award : Dr. Helena Safavi-Hemami
  • CEO Roundtable: Beyond Pharma
  • Entrepreneur Workshop
  • Women Rising: Elevating Women in Leadership Roles

BPS 2022

Photos
Proceedings

Nov 7-10, 2022
(Boulder, CO)

Highlights:

  • Meienhofer Keynote: Dr. Stephen Kent
  • Spotlight on Venomous Peptides
  • CEO Roundtable
  • Start-up Workshop
View All

Information for BPS Presenters

The Boulder Peptide Foundation was established to further the science and knowledge of peptide technology to develop novel therapeutics, biomaterials, medical diagnostics and other beneficial uses for mankind. As part of this goal we run several programs to support career advancement, seminars and educational events. Join us on our mission to expand the applications of peptide science.

Information for BPS Presenters

The purpose of the Boulder Peptide Symposium is to encourage sharing of information related to peptide therapeutic development with an emphasis on the technical, scientific and regulatory aspects of the pharmaceutical development. Presentations that demonstrate original thinking or share experiences from case studies in product development shall receive priority over others.

The Boulder Peptide Symposium offers multiple opportunities for participants to present.

Oral Presentations in Scientific Sessions

The session topics for Scientific Program are Peptides in the Clinic, Drug Delivery, Chemistry of Complex Peptides, Spotlight on Discovery, and Peptide Showcase. Abstracts may be submitted via the Apply to Present page on the website. Submissions will be reviewed by the Scientific Advisory Board on a monthly basis and the speaker will be notified of a decision.

Presentation length: Format is 25-30 minutes slide presentation with 5-10 minutes for Q&A, with the exception of Peptide Showcase talks which are 10 minute slide presentations with 5 minutes for Q&A. Please confirm with your session chair to confirm the exact presentation length.

Invited Speakers: Speakers are requested to supply their presentation details 30 days after receiving an invitation to present.

Program Book Deadline: Final abstract and title must be provided no later than September 1st. No changes to the program are possible after this date.

Presentation Format: Oral presenters please provide your presentation slides to the A/V table on the day of your presentation.

Lodging: All speakers are requested to reserve their own room. Discount rates at the conference hotel are available until August 16th.

Registration: All speakers, excluding sponsored presentation speakers, receive a complimentary registration upon approval of the abstract.

Peptide Showcase Description

The Peptide Showcase is an opportunity for an individual or company to “showcase” new ideas, technology and pipeline assets. Priority shall be given to presentations from biotech and startup companies. Service providers and vendors are not eligible. Speakers in the session receive a complimentary event registration.

Posters

Posters can be presented on any topic relevant to peptides including original research, innovative products and technologies.

Eligibility- Any attendee (from academia, industry, biotech or vendor/sponsor) can present a poster. The presentation must contain original scientific thinking. To submit a poster go to the Submit a Poster link from the meeting menu. All submissions are reviewed on a rolling basis and will be notified of approval. September 1st is the last day to submit a poster abstract. Approved posters are published on the BPF website.

A 30 ” x 40″ board shall be provided with thumb tacks. Board will be on an easel and can be rotated for either landscape or portrait formats. Once you apply for a poster, you will get email confirmation that your poster was accepted. The poster session and number assignments will be emailed one week before the Symposium.

Poster boards shall be available for display from 8am to 8pm the day of your assigned poster session. See the program agenda for the poster session schedule.

Public Release

Every presentation at the Boulder Peptide Symposium is automatically recorded. Speakers are required to give consent for sharing of the presentation video with the peptide community.

Refund Policy - Terms and Conditions - Privacy Policy